123 related articles for article (PubMed ID: 26722329)
1. Heterozygous p.I171V mutation of the
Kałużna EM; Rembowska J; Ziółkowska-Suchanek I; Świątek-Kościelna B; Gabryel P; Dyszkiewicz W; Nowak JS
Oncol Lett; 2015 Nov; 10(5):3300-3304. PubMed ID: 26722329
[TBL] [Abstract][Full Text] [Related]
2. Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions.
Dzikiewicz-Krawczyk A; Mosor M; Januszkiewicz D; Nowak J
Mutagenesis; 2012 May; 27(3):337-43. PubMed ID: 22131123
[TBL] [Abstract][Full Text] [Related]
3. Inherited NBN Mutations and Prostate Cancer Risk and Survival.
Rusak B; Kluźniak W; Wokołorczykv D; Stempa K; Kashyap A; Gronwald J; Huzarski T; Dębniak T; Jakubowska A; Masojć B; Akbari MR; Narodv SA; Lubiński J; Cybulski C
Cancer Res Treat; 2019 Jul; 51(3):1180-1187. PubMed ID: 30590007
[TBL] [Abstract][Full Text] [Related]
4. Effect of irradiation on DNA synthesis,
Nowak J; Świątek-Kościelna B; Kałużna EM; Rembowska J; Dzikiewicz-Krawczyk A; Zawada M; Januszkiewicz-Lewandowska D
Arch Med Sci; 2017 Mar; 13(2):283-292. PubMed ID: 28261280
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene.
Ziólkowska I; Mosor M; Wierzbicka M; Rydzanicz M; Pernak-Schwarz M; Nowak J
Cancer Sci; 2007 Nov; 98(11):1701-5. PubMed ID: 17894553
[TBL] [Abstract][Full Text] [Related]
6. The importance of making ends meet: mutations in genes and altered expression of proteins of the MRN complex and cancer.
Dzikiewicz-Krawczyk A
Mutat Res; 2008; 659(3):262-73. PubMed ID: 18606567
[TBL] [Abstract][Full Text] [Related]
7. Functional variants in NBS1 and cancer risk: evidence from a meta-analysis of 60 publications with 111 individual studies.
Gao P; Ma N; Li M; Tian QB; Liu DW
Mutagenesis; 2013 Nov; 28(6):683-97. PubMed ID: 24113799
[TBL] [Abstract][Full Text] [Related]
8. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
Roznowski K; Januszkiewicz-Lewandowska D; Mosor M; Pernak M; Litwiniuk M; Nowak J
Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
[TBL] [Abstract][Full Text] [Related]
9. Is the NBN gene mutation I171V a potential risk factor for malignant solid tumors in children?
Nowak J; Mosor M; Nowicka K; Rembowska J; Januszkiewicz D
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e248-9. PubMed ID: 21436738
[TBL] [Abstract][Full Text] [Related]
10. NBS1 Heterozygosity and Cancer Risk.
di Masi A; Antoccia A
Curr Genomics; 2008 Jun; 9(4):275-81. PubMed ID: 19452044
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.
Nowak J; Mosor M; Ziółkowska I; Wierzbicka M; Pernak-Schwarz M; Przyborska M; Roznowski K; Pławski A; Słomski R; Januszkiewicz D
Eur J Cancer; 2008 Mar; 44(4):627-30. PubMed ID: 18280732
[TBL] [Abstract][Full Text] [Related]
12. Allelic modification of breast cancer risk in women with an NBN mutation.
Rusak B; Kluźniak W; Wokołorczyk D; Stempa K; Kashyap A; Rudnicka H; Gronwald J; Huzarski T; Dębniak T; Jakubowska A; Szwiec M; Akbari MR; Narod SA; Lubiński J; Cybulski C;
Breast Cancer Res Treat; 2019 Nov; 178(2):427-431. PubMed ID: 31410679
[TBL] [Abstract][Full Text] [Related]
13. Association of the nibrin gene (
Uzunoglu H; Korak T; Ergul E; Uren N; Sazci A; Utkan NZ; Kargi E; Triyaki Ç; Yirmibesoglu O
Biomed Rep; 2016 Mar; 4(3):369-373. PubMed ID: 26998278
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of the BRCT tandem domains of nibrin by the 657del5 mutation affects the DNA damage response less than the Arg215Trp mutation.
Mendez G; Cilli D; Berardinelli F; Viganotti M; Ascenzi P; Tanzarella C; Antoccia A; di Masi A
IUBMB Life; 2012 Oct; 64(10):853-61. PubMed ID: 22941933
[TBL] [Abstract][Full Text] [Related]
15. NBS1 variant I171V and breast cancer risk.
Bogdanova N; Schürmann P; Waltes R; Feshchenko S; Zalutsky IV; Bremer M; Dörk T
Breast Cancer Res Treat; 2008 Nov; 112(1):75-9. PubMed ID: 18049891
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of CHEK2 and NBN mutations in the macedonian population.
Kostovska IM; Jakimovska M; Kubelka-Sabit K; Karadjozov M; Arsovski A; Stojanovska L; Plaseska-Karanfilska D
Balkan J Med Genet; 2015 Jun; 18(1):47-54. PubMed ID: 26929905
[TBL] [Abstract][Full Text] [Related]
17. NBN 657del5 heterozygous mutations and colorectal cancer risk in the Czech Republic.
Pardini B; Naccarati A; Polakova V; Smerhovsky Z; Hlavata I; Soucek P; Novotny J; Vodickova L; Tomanova V; Landi S; Vodicka P
Mutat Res; 2009 Jun; 666(1-2):64-7. PubMed ID: 19393249
[TBL] [Abstract][Full Text] [Related]
18. Identification of the interactors of human nibrin (NBN) and of its 26 kDa and 70 kDa fragments arising from the NBN 657del5 founder mutation.
Cilli D; Mirasole C; Pennisi R; Pallotta V; D'Alessandro A; Antoccia A; Zolla L; Ascenzi P; di Masi A
PLoS One; 2014; 9(12):e114651. PubMed ID: 25485873
[TBL] [Abstract][Full Text] [Related]
19. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland.
Steffen J; Varon R; Mosor M; Maneva G; Maurer M; Stumm M; Nowakowska D; Rubach M; Kosakowska E; Ruka W; Nowecki Z; Rutkowski P; Demkow T; Sadowska M; Bidziński M; Gawrychowski K; Sperling K
Int J Cancer; 2004 Aug; 111(1):67-71. PubMed ID: 15185344
[TBL] [Abstract][Full Text] [Related]
20. The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?
Seemanova E; Varon R; Vejvalka J; Jarolim P; Seeman P; Chrzanowska KH; Digweed M; Resnick I; Kremensky I; Saar K; Hoffmann K; Dutrannoy V; Karbasiyan M; Ghani M; Barić I; Tekin M; Kovacs P; Krawczak M; Reis A; Sperling K; Nothnagel M
PLoS One; 2016; 11(12):e0167984. PubMed ID: 27936167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
